Citations

Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4784 total record number 156 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 157 out of 479
4784 citations found

Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis

Jin, J;Smith, MD;Kersbergen, CJ;Kam, TI;Viswanathan, M;Martin, K;Dawson, TM;Dawson, VL;Zack, DJ;Whartenby, K;Calabresi, PA;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Prospective isolation of non-hematopoietic cells of the niche and their differential molecular interactions with HSCs

Mende, N;Jolly, A;Percin, GI;Gnther, M;Rostovskaya, M;Krishnan, SM;Oostendorp, RAJ;Dahl, A;Anastassiadis, K;Hfer, T;Waskow, C;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Tolerogenic signaling of alveolar macrophages induces lung adaptation to oxidative injury

Allard, B;Panariti, A;Pernet, E;Downey, J;Ano, S;Dembele, M;Nakada, E;Fujii, U;McGovern, TK;Powell, WS;Divangahi, M;Martin, JG;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Raw Cow’s Milk Reduces Allergic Symptoms in a Murine Model for Food Allergy-A Potential Role For Epigenetic Modifications

Abbring, S;Wolf, J;Ayechu-Muruzabal, V;Diks, MAP;Alhamwe, BA;Alhamdan, F;Harb, H;Renz, H;Garn, H;Garssen, J;Potaczek, DP;van Esch, BCAM;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Experimental DesignTolerance Induction, Sensitization and Challenges:

    … Following this oral tolerance induction period, mice were sensitized i.g. once a week for five weeks to the hens egg protein ovalbumin (OVA; 20 mg/0.5 mL PBS; grade V; Sigma-Aldrich, Zwijndrecht, The Netherlands) while using 10 µg cholera toxin (CT; List Biological Laboratories, Campbell, CA, USA) as an adjuvant (days 0, 7, 14, 21, 28; n = 8/group). Sham-sensitized control mice (n = 6) received CT alone (10 µg/0.5 mL PBS). …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases

Haile, PA;Casillas, LN;Votta, BJ;Wang, GZ;Charnley, AK;Dong, X;Bury, MJ;Romano, JJ;Mehlmann, JF;King, BW;Erhard, KF;Hanning, CR;Lipshutz, DB;Desai, BM;Capriotti, CA;Schaeffer, MC;Berger, SB;Mahajan, MK;Reilly, MA;Nagilla, R;Rivera, EJ;Sun, HH;Kenna, JK;Be

Product: ULTRA PURE LPS from Escherichia coli O111:B4

  • Human PBMC Synergy Assays:

    Human peripheral blood mononuclear cells were isolated using single step FicollPaque method, then washed three times to remove platelets and resuspended in RPMI-1640 supplemented with 10% HI-FCS, 2 mM L-glutamine, 2.5 mM HEPES + penicillin/streptomycin) at 10000 cells/well in 96- well flat bottom plate. Several pilot experiments (minimum of four different donors, and typically six) were performed using a full dose response of ligand to define the range of the EC10 to EC30 of MDP (Invivogen TLRL-MDP) and Pam2CSK4 (Invivogen TLRL-pca2-1), respectively, as it was determined that this was the concentration needed to reliability and consistently demonstrate synergy using both ligands. Typically, three concentrations of each of the two ligands were evaluated in a pairwise matrix to account for minor variations between donors, and also a full doseresponse was assessed to compare to the average of all donors tested. Compounds were preincubated for 30 min, and then ligands were added, and plates were incubated for 4 h at 37 C with 5% CO2. Supernatants were assessed for human proinflammatory cytokines using an MSD four plex kit (K15025C-4). Raw data were converted to cytokines concentrations using a four-parameter curve fit with 1/y2 weighting as recommended by the manufacturer using PerkinElmer Workout software. Cytokine values were then graphed into dose response curves using Sigma Plot software and an IC50 was determined for individual and composite graphs. The synergistic response was compared to the response of each of the ligands alone for each donor. A similar approach was also used for MDP and Ultrapure LPS (List Biologicals 421), MDP and Flagellin (Invivogen TLRL-stfla), and last MDP and IL-1ineb (Biolegend 57006). 

    Product #421 – ULTRA PURE LPS from Escherichia coli O111:B4

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • … OVA (1 mg) was given by oral gavage (with each mouse receiving 10 µg of cholera toxin (CT); List Biologicals, Campbell, CA) twice a week for 4 weeks, and various monosaccharide-conjugated forms of OVA (OVA-Glu, OVA-Man, OVA-Fru, and OVA-Rib) and the control OVA were administered orally thrice a week for 4 weeks, as described in Figure 1.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Lysophosphatidic acid up-regulates IL-10 production to inhibit TNF- synthesis in Ms stimulated with LPS

Ciesielska, A;Hromada-Judycka, A;Ziemliska, E;Kwiatkowska, K;

Product: ULTRA PURE LPS from Escherichia coli O111:B4

Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease

Cho, A;Caldara, AL;Ran, NA;Menne, Z;Kauffman, RC;Affer, M;Llovet, A;Norwood, C;Scanlan, A;Mantus, G;Bradley, B;Zimmer, S;Schmidt, T;Hertl, M;Payne, AS;Feldman, R;Kowalczyk, AP;Wrammert, J;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • Reagents:

    rCTxB List Labs Cat# 103B

    Tetanus toxoid List Biological Laboratories Cat# 191A

    ELISA:

    … Additional ELISA assays were performed by coating plates with 1 µg/mL recombinant protein antigens CtxB (Kauffman et al., 2016) and influenza HA-antigen (A/California/7/2009, eEnzyme). Minimum effective concentration was determined as the minimal concentration of mAb at which an OD signal was detectable 3-fold above the background signal measured by a negative control.

    To determine serum titers against tetanus-toxoid protein, ELISA plates (ThermoScientific) were coated with 0.5 µg/mL of recombinant Tetanus toxoid (List Biological Laboratories) diluted in PBS and incubated overnight at 4°C. …

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt
    Product #191 – Tetanus Toxoid from Clostridium tetani